https://doi.org/10.4081/reumatismo.2023.1568
Epidemiology and demographics of cutaneous lupus erythematosus in Colombia between 2015 and 2019
Submitted: 15 February 2023
Accepted: 14 April 2023
Published: 8 May 2023
Accepted: 14 April 2023
Abstract Views: 1018
PDF: 625
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Cutaneous lupus erythematosus (CLE) is classified into three groups - acute, subacute, and chronic - based on clinical and histopathological characteristics. The risk of systemic manifestations varies among these groups. There are few studies on CLE epidemiology. For this reason, this paper aims to describe CLE prevalence and demographics in Colombia between 2015 and 2019. This descriptive, cross-sectional study used the international classification of diseases, tenth revision, for CLE subtypes, utilizing official data from the Colombian Ministry of Health. In people older than 19 years, 26,356 CLE cases were registered, yielding a prevalence of 76 cases per 100,000 population. CLE was more frequent in females, at a 5:1 ratio compared to males. The most common clinical presentation was discoid lupus erythematosus, in 45% of cases. The majority of cases occurred in people between 55 and 59 years old. This is the first study that describes CLE demographics in adults in Colombia. Findings regarding clinical subtypes and female predominance are consistent with those in the medical literature.
Wenzel J. Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies. Nat Rev Rheumatol. 2019; 15: 519-32.
DOI: https://doi.org/10.1038/s41584-019-0272-0
Blake SC, Daniel BS. Cutaneous lupus erythematosus: a review of the literature. Int J Womens Dermatol. 2019; 5: 320-9.
DOI: https://doi.org/10.1016/j.ijwd.2019.07.004
Ogunsanya M, Kalb S, Kabaria A, Chen S. A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus. Br J Dermatol. 2017; 176: 52-61.
DOI: https://doi.org/10.1111/bjd.14868
Koch K, Tikly M. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus. 2019; 28: 1021-6.
DOI: https://doi.org/10.1177/0961203319856091
Jarrett P, Thornley S, Scragg R. Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. Lupus. 2016; 25: 1497-502.
DOI: https://doi.org/10.1177/0961203316651745
Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ, et al. Epidemiology of systemic lupus erythematosus and cutaneous lupus in a predominantly white population in the United States. Arthritis Care Res. 2015; 67: 817-28.
DOI: https://doi.org/10.1002/acr.22502
Deligny C, Sainte Marie D, Clyti E, Arfi S, Couppié P. Pure cutaneous lupus erythematosus in a population of African descent in French Guiana: a retrospective population-based description. Lupus. 2012; 21: 1467-71.
DOI: https://doi.org/10.1177/0961203312458167
De Freitas THP, Proença NG. Chronic cutaneous lupus erythematosus: study of 290 patients [Article in Portuguese]. An Bras Dermatol. 2003; 78: 703-12.
DOI: https://doi.org/10.1590/S0365-05962003000600005
Ministerio de salud de Colombia. Cifras de aseguramiento en salud. 2021. Available from: https://www.minsalud.gov.co/proteccionsocial/Paginas/cifras-aseguramiento-salud.aspx.
Fernández-Ávila DG, Bernal-Macías S, Rincón-Riaño DN, Gutiérrez Dávila JM, Rosselli D. Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012-2016. Lupus. 2019; 28: 1273-8.
DOI: https://doi.org/10.1177/0961203319864168
Petersen MP, Möller S, Bygum A, Voss A, Bliddal M. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark. Lupus. 2018; 27: 1424-30.
DOI: https://doi.org/10.1177/0961203318777103
Grönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011; 164: 1335-41.
DOI: https://doi.org/10.1111/j.1365-2133.2011.10272.x
Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR. Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features. Semin Arthritis Rheum. 1992; 21: 221-6.
DOI: https://doi.org/10.1016/0049-0172(92)90052-F
How to Cite
Fernández Ávila, D., Rivera Maldonado, M., & Charry Anzola, L. (2023). Epidemiology and demographics of cutaneous lupus erythematosus in Colombia between 2015 and 2019. Reumatismo, 75(1). https://doi.org/10.4081/reumatismo.2023.1568
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- Y. Emad, T. Gheita, H. Darweesh, P. Klooster, R. Gamal, H. Fathi, N. El-Shaarawy, M. Gamil, M. Hawass, R.M. El-Refai, H. Al-Hanafi, S. Abd-Ellatif, A. Ismail, J. Rasker, Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity , Reumatismo: Vol. 70 No. 2 (2018)
- E. Cipriano, F. Ceccarelli, L. Massaro, F. R. Spinelli, C. Alessandri, C. Perricone, G. Valesini, F. Conti, Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio , Reumatismo: Vol. 67 No. 2 (2015)
- D. Jain, H.K. Aggarwal, V. Kaverappa, S. Dhayia, P. Jain, S. Yadav, Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case , Reumatismo: Vol. 65 No. 6 (2013)
- L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria, Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus , Reumatismo: Vol. 64 No. 5 (2012)
- M. A. Marie, R. E. Abu Khalil, H. M. Habib, Urinary CXCL10: a marker of nephritis in lupus patients , Reumatismo: Vol. 65 No. 6 (2013)
- M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani, Typing TREX1 gene in patients with systemic lupus erythematosus , Reumatismo: Vol. 67 No. 1 (2015)
- M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani, The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus , Reumatismo: Vol. 68 No. 3 (2016)
- H.K. Aggarwal, D. Jain, A. Mittal, A. Rao, R.K. Yadav, P. Jain, Systemic lupus erythematosus presenting as fulminant lupus pneumonitis: a rare case report , Reumatismo: Vol. 68 No. 1 (2016)
- G. Pasero, P. Marson, Short story of antirheumatic therapy.VIII. The immunodepressants , Reumatismo: Vol. 64 No. 1 (2012)
- M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini, Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? , Reumatismo: Vol. 64 No. 5 (2012)
You may also start an advanced similarity search for this article.
